Skip to main content
. Author manuscript; available in PMC: 2016 Mar 14.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2014 May 24;89(4):830–838. doi: 10.1016/j.ijrobp.2014.03.034

Fig. 2.

Fig. 2

Comparison of overall survival according to KRASG12D mutation and elevated baseline hepatocyte growth factor (HGF) in PDAC after neoadjuvant chemoradiation.